BioSpace News Archive

The U.S. Food and Drug Administration authorized the marketing of Philip Morris Products S.A.'s “IQOS Tobacco Heating System” as modified risk tobacco products.

There is a constant influx of new information from various sources, but Gibson Diagnostic Labs has compiled the latest recommendations from the Centers for Medicare and Medicaid Services (CMS) and the Center for Disease Control and Prevention (CDC) for easy reference.

Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the consumer level of one lot of Daptomycin for Injection, 500 mg/vial due to the presence of particulate matter found in one single-dose vial manufactured by Mylan Laboratories Limited’s Specialty Formulation Facility

The unprecedented emergency authorization of remdesivir for treating COVID-19 only four months after the virus was discovered was enabled by decades of basic research on the drug’s biological target and drugs with similar parent structures, and was supported by $6.5 billion in NIH funding, according to a study from Bentley University

Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded the company with three biomanufacturing contracts with a combined value of more than $16 million.

QC-validated cell lines optimized to work alongside Horizon’s Edit-R predesigned sgRNA products and DharmaFECT transfection reagents

Pac Roots Cannabis Corp. (“PacRoots” or the “Company”) (CSE:PACR), is pleased to announce the execution of a definitive Investment Agreement with Rock Creek Farms (“RCF”) on a 100 acre commercial hemp operation, in Rock Creek, British Columbia.

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

uLab Systems, the creator of uLab, the treatment planning software and aligner system designed for orthodontists, has announced two significant additions to their senior leadership team. Amir Abolfathi has been appointed as Chief Executive Officer and Nicola Downes has been appointed as Chief Financial Officer in preparation for uLab’s full-scale aligner launch in September.

The race is on to find a vaccine for COVID-19, the illness caused by the novel coronavirus.